黄小平,吴云辉,王 艳,甘建和
慢加急性肝衰竭前期患者血清M30和M65水平预测预后价值探讨*
黄小平,吴云辉,王艳,甘建和
目的探讨慢加急性肝衰竭前期(pre-ACLF)患者血清M30和M65水平在早期诊断慢加急性肝衰竭(ACLF)患者的价值。方法采用ELISA法检测35例pre-ACLF患者(痊愈20例、进展15例)、40例HBV相关ACLF患者(生存20例,死亡20例)、20例慢性乙型肝炎患者(CHB)和20例健康对照者血清M 30和M65水平,分析其对pre-ACLF及ACLF患者临床转归的预测价值。结果ACLF组和pre-ACLF组血清M30和M65水平均显著高于健康对照组或CHB患者,ACLF组显著高于pre-ACLF组(P<0.05);pre-ACLF进展组血清M30和M65[分别为(493.80±143.85)U/L和(712.47±305.67)U/L]与痊愈组[分别为(351.40±127.78)U/L和(448.15±165.14)U/L]比,差异具有统计学意义(P<0.05);pre-ACLF进展组与ACLF患者比,血清M30和M65水平[分别为(503.29±184.43)U/L和(746.99±275.19)U/L]均无显著性差异(P>0.05);以血清M30和M 65水平鉴别诊断Pre-ACLF临床转归的ROC曲线下面积(AUC)分别为0.877和0.867;当M30≥453.70 U/L时,其预测预后的灵敏度和特异度分别为0.867和0.850;当M65≥626.71 U/L时,其早期预测ACLF的灵敏度和特异度分别为0.800和0.850。死亡的ACLF患者血清M30和M65水平虽高于ACLF好转组,但差异无统计学意义。结论M30和M65是反应肝衰竭及肝衰竭前期患者肝细胞坏死或凋亡较敏感的指标,可用于早期诊断ACLF。
慢加急性肝衰竭;慢加急性肝衰竭前期;早期诊断;M30抗原;M65抗原
【Abstract】Objective To evaluate serum M30 and M65 levels in patients with acute-on-chronic pre-liver failure(pre-ACLF)and to investigate their value for early diagnosis of acute-on-chronic liver failure(ACLF). Methods Serum M30 and M 65 levels in patients with pre-ACLF(n=35),ACLF(n=40),chronic hepatitis B(CHB,n=20)and healthy controls(n=20)were determined by enzyme-linked immunoabsorbent assay.The clinical significance for early diagnosis of ACLF was analyzed.Results Significantly higher serum M30 and M65 levels were found in patients with ACLF and with pre-ACLF compared with CHB or healthy controls(P<0.05); In pre-ACLF patients,serum M30 and M65 levels[(493.80±143.85)U/L and(712.47±305.67)U/L]were higher in 15 patients who progressed to ACLF than 20 recovered[(351.40±127.78)U/L and(448.15±165.14)U/L, respectively,P<0.05];No significant difference was found in serum M 30 and M 65 levels between 15 patients with pre-ACLF who switched to ACLF and 40 patients with ACLF(P>0.05);The area under receiver operating characteristic curve(AUC)demonstrated that both serum M30 and M65 had diagnostic value(AUC≥0.80)in identifying early ACLF from pre-ACLF patients(0.877 and 0.867,respectively);When serum M 30 levels were≥453.70 U/L,the sensitivity and specificity for diagnosis of ACLF was 0.867and 0.850,respectively,and whenserum M65 levels were≥626.71 U/L,the sensitivity and specificity for diagnosis of ACLF was 0.800 and 0.850,respectively;No significant difference was found in serum M30 and M65 levels between 20 survived patients with ACLF as compared with 20 died(P>0.05).Conclusions In patients with pre-ACLF,serum M30 and M65 levels may serve as important biomarkers for early diagnosis of ACLF.
【Key words】Acute-on-chronic liver failure;Acute-on-chronic pre-liver failure;Early diagnosis;M 30;M65
慢加急性肝衰竭(Acute-on-chronic liver failure,ACLF)患者病情进展迅速,预后差,病死率高达50%~90%[1,2]。在欧美国家,其发病的病因以慢性酒精中毒为主,而在我国及其它亚洲国家,慢性HBV感染是ACLF的主要发病病因[3]。目前,肝移植仍然是治疗ACLF最为有效的手段,但ACLF患者病情往往进展迅速,多数患者在等待供体的过程中迅速出现严重并发症而失去手术机会[4]。早期诊断和合理治疗是提高ACLF患者生存率的重要措施。近年来,慢加急性肝衰竭前期(Acute-on-chronic pre-liver failure,pre-ACLF)作为ACLF早期诊断的重要概念逐渐受到重视,并于2012年被引入我国《肝衰竭诊治指南》[5]。但……